ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Mexico » Rheumatology

Top Rheumatology Prescribers in New Mexico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SUZANNE GRAY MD

Rheumatology

3,193

$522K

175
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$164
Average prescription price

Avg: $167

FRANK OSULLIVAN MD

Rheumatology

3,349

$840K

548
409 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$251
Average prescription price

Avg: $167

JACQUELINE DEAN MD

Rheumatology

2,707

$330K

244
144 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$122
Average prescription price

Avg: $167

SHARON NUNEZ MD

Rheumatology

1,032

$129K

172
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$125
Average prescription price

Avg: $167

JAMES STEIER MD

Rheumatology

4,306

$905K

356
243 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 12%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$210
Average prescription price

Avg: $167

PETER ROSANDICH M.D.

Rheumatology

763

$108K

92
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$142
Average prescription price

Avg: $167

RALPH WILLIAMS M.D.

Rheumatology

505

$93.6K

62
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

29%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$185
Average prescription price

Avg: $167

LYLE AMER MD

Rheumatology

5,066

$306K

343
169 are 65+

28%
patients receiving schedule two controlled substances

Avg: 7%

33%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $167

LEROY PACHECO MD

Rheumatology

5,727

$611K

395
248 are 65+

27%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$107
Average prescription price

Avg: $167

WILMER SIBBITT MD

Rheumatology

462

$51.1K

86
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$111
Average prescription price

Avg: $167

EDDIE BENGE MD

Rheumatology

3,174

$441K

398
296 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$139
Average prescription price

Avg: $167

ART SNYDER MD

Rheumatology

5,700

$1.14M

587
407 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$199
Average prescription price

Avg: $167

MONICA SNOWDEN M.D.

Rheumatology

257

$56.4K

79
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$219
Average prescription price

Avg: $167

JULIET COQUIA MD

Rheumatology

3,413

$685K

395
288 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$201
Average prescription price

Avg: $167

MURRAY SOKOLOFF MD

Rheumatology

2,628

$387K

191
123 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$147
Average prescription price

Avg: $167

JAYASHREE SINHA MD

Rheumatology

2,530

$610K

298
160 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$241
Average prescription price

Avg: $167

FREDRICA SMITH MD

Rheumatology

1,716

$540K

134
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$315
Average prescription price

Avg: $167

VIJAYALAKSHMI KUMAR MD

Rheumatology

6,196

$749K

681
502 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$121
Average prescription price

Avg: $167

ZAIN ABIDEEN M.D

Rheumatology

814

$151K

91
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$186
Average prescription price

Avg: $167

RODERICK FIELDS M.D.

Rheumatology

558

$150K

163
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$269
Average prescription price

Avg: $167

THOMAS RAMAGE M.D.

Rheumatology

3,140

$696K

349
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$222
Average prescription price

Avg: $167

ADRIAN MICHAEL M.D.

Rheumatology

485

$117K

113
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$242
Average prescription price

Avg: $167

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank